Clinical Trial Update: Sintilimab Combined With Chemotherapy for Adjuvant Treatment of Mucosal Melanoma After Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sintilimab in combination with chemotherapy as adjuvant treatment for mucosal melanoma after surgery; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucosal Melanoma

Drugs mentioned

• Sintilimab (sintilimab)

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: Mucosal Melanoma, PD-L1 Positive | Phase 2 | Status: RECRUITING